Clock proteins govern circadian physiology and their function is regulated by various mechanisms. Here we demonstrate that Casein kinase (CK)-2a phosphorylates the core circadian regulator BMAL1. Gene silencing of CK2a or mutation of the highly conserved CK2-phosphorylation site in BMAL1, Ser90, result in impaired nuclear BMAL1 accumulation and disruption of clock function. Notably, phosphorylation at Ser90 follows a rhythmic pattern. These findings reveal that CK2 is an essential regulator of the mammalian circadian system.
Clock proteins govern circadian physiology and their function is regulated by various mechanisms. Here we demonstrate that Casein kinase (CK)-2a phosphorylates the core circadian regulator BMAL1. Gene silencing of CK2a or mutation of the highly conserved CK2-phosphorylation site in BMAL1, Ser90, result in impaired nuclear BMAL1 accumulation and disruption of clock function. Notably, phosphorylation at Ser90 follows a rhythmic pattern. These findings reveal that CK2 is an essential regulator of the mammalian circadian system.
The circadian clock orchestrates intrinsic timing in most organisms and controls a large variety of physiological and metabolic programs 1 . The molecular core of the circadian clock is constituted by multiple gene products that operate in transcriptional-translational feedback loops 1, 2 . The BMAL1-CLOCK heterodimer is central to the clock mechanism as it drives and maintains circadian oscillations. Several studies indicate that clock proteins are important targets of post-translational modifications [3] [4] [5] [6] [7] , and their rhythmic phosphorylation seems to be a crucial step for regulated function 2, 8, 9 . Indeed, BMAL1 phosphorylation is rhythmic in serum shock-synchronized fibroblasts 10 . Furthermore, drastic circadian phenotypes in the fly are caused by mutations in kinases such as Doubletime (DBT), the fly ortholog of CKIe, Shaggy (SGG), the fly ortholog of Glycogen synthase kinase 3 (GSK3), and CK2. Drosophila melanogaster CK2 specifically regulates the nuclear entry of Period (PER), thereby controlling the fly clock [11] [12] [13] . In mammals, the tau mutant phenotype, characterized by impaired circadian rhythmicity, is due to a mutation in the gene encoding the clock-regulating kinase CKIe 14 .
Microsequencing of purified p45 PFK , a kinase previously implicated in circadian control in mammals 15 , demonstrates that it corresponds to CK2a ( Supplementary Fig. 1 online) . Notably, purified p45 PFK phosphorylates BMAL1 and CLOCK in vitro 15, 16 ( Supplementary  Fig. 2 online) .
The CK2 holoenzyme is constituted by two copies of the catalytic (CK2a) and regulatory (CK2b) subunits (a2b2). The CK2a monomer also exists as an active form in vivo. To assess the role of CK2b in modulating CK2a-mediated BMAL1 phosphorylation, we co-incubated the subunits in kinase assays. CK2a alone phosphorylated GST-BMAL1, whereas CK2b inhibited BMAL1 phosphorylation in a dose-dependent manner ( Fig. 1 ; see Supplementary Methods online). These results demonstrate that CK2a monomer phosphorylates BMAL1.
To establish the physiological role of CK2a-mediated BMAL1 phosphorylation, we used microRNA interference (miR)-mediated silencing in dexamethasone (Dex)-synchronized NIH-3T3 mouse fibroblasts. A miR-CK2a silencing vector specifically reduced CK2a levels to less than the half that of the control (P ¼ 0.002) (Fig. 2a) , resulting in markedly impaired circadian Per2 oscillation, as monitored by real-time Per2 promoter-driven luciferase bioluminescence 4 (Fig. 2b) . In fact, after a first peak with significantly reduced amplitude, Per2 oscillation was almost abolished in miR-CK2a-transfected cells (Fig. 2b) . These results were confirmed by using an alternative target sequence (Supplementary Fig. 3 online) . Thus, CK2a is essential for mammalian circadian rhythmicity.
Notably, silencing of CK2a leads to substantial cytoplasmic BMAL1 retention 24 h after Dex treatment (Fig. 2c) , a time when BMAL1 is normally mostly nuclear 10 . As the function of the CLOCK-BMAL1 complex is intimately dependent on the nuclear translocation of BMAL1 (ref. 17) , we speculate that CK2a exerts its control on the mammalian circadian clock by dictating BMAL1 intracellular localization. This is reminiscent of the role described for the D. melanogaster CK2 in controlling PER nuclear entry 13 . We searched the BMAL1 primary sequence for CK2 consensus phosphoacceptor sites (S/T-X-X-D/E). The serine residue at position 90 is highly conserved among all vertebrate BMAL1s ( Supplementary  Fig. 4b online) , and a MALDI-TOF/MS analysis indicated that it is indeed a potential CK2-phosphorylation site ( Supplementary  Fig. 4a ). Notably, Ser90 is not conserved in D. melanogaster CYCLE, the fly counterpart of BMAL1, consistent with the notion that CK2a cannot phosphorylate CYCLE 13 .
To establish the role of BMAL1 Ser90 phosphorylation in circadian function, we performed rescue experiments by expressing wild-type BMAL1 (BMAL1-WT), BMAL1-S90A mutant or GFP in mouse embryonic fibroblasts (MEFs) derived from Bmal1-null mice, which have a dysfunctional circadian clock 4, 6, 7 (Fig. 2d) . Per2 expression was monitored in Dex-synchronized MEFs by a real-time reporter assay. BMAL1-WT rescued circadian Per2 expression in Dex-synchronized MEFs ( Supplementary Fig. 5 online) , whereas the BMAL1-S90A mutant was unable to do so (Fig. 2f) , despite its having normal DNA binding activity (data not shown). These results indicate that BMAL1 phosphorylation at Ser90 is essential for circadian gene expression.
Ectopically expressed BMAL1-WT accumulated in the nucleus 24 h after Dex treatment (Fig. 2f) , paralleling the behavior of native BMAL1 in fibroblasts 10 . In contrast, BMAL1-S90A remained mostly cytoplasmic (Fig. 2f) . Consistent with previous reports indicating a matching localization pattern between BMAL1 and CLOCK 17 , BMAL1-S90A suppressed nuclear CLOCK accumulation, possibly because of its decreased interaction potential with CLOCK (Supplementary Fig. 6 online) . These data are consistent with the change in BMAL1 localization upon CK2a silencing (Fig. 2c) and stress the notion that circadian function requires phosphorylation of BMAL1 and its nuclear accumulation.
To assess the temporal pattern of Ser90 phosphorylation in vivo, we raised an antibody specific for Ser90-phosphorylated BMAL1. Specificity was validated because this antibody (P-BMAL1-S90) detects Myc-BMAL1 but not the Myc-BMAL1-S90A mutant or Myc-GFP ( Supplementary Fig. 7 online) . Using the P-BMAL1-S90 antibody, we examined whether silencing of CK2a indeed impaired BMAL1 phosphorylation at Ser90. The P-BMAL1-S90 antibody detected a band corresponding to the highly phosphorylated protein (apparent migration pattern corresponding to about 85-90 kDa) in the concentrated BMAL1 immunoprecipitated from the control vector-transfected NIH-3T3 cells at 24 h after Dex treatment (Fig. 3a) . The targeting vectors for miR-CK2a substantially decreased the P-BMAL1-S90 signal (Fig. 3a) . Notably, knockdown of CK2a strongly affects the total phosphorylation state of BMAL1, suggesting that CK2a may influence or modulate multiple phosphorylation events on BMAL1 by other kinases, including ERKs and CKIe 18, 19 .
Next, we examined whether P-BMAL1-S90 levels oscillated in vivo. In Dex-synchronized NIH-3T3 cells, Ser90 phosphorylation showed a rhythmic pattern with peaks at 20-24 h and 44-48h, paralleling PER1 level oscillation (Fig. 3b) . At peaking times, the P-BMAL1-S90 signal gradually shifted to a higher molecular weight (B90 kDa), corresponding to the hyperphosphorylated forms. The timing of BMAL1-S90 phosphorylation fits with the cyclic nuclear entry of BMAL1 in Dex-synchronized cells (data not shown) and serum shock-synchronized cells 10 . The levels of CK2 subunits (a¢ is a subtype of CK2 catalytic subunit) are basically constant during the circadian cycle (Fig. 3b) ; thus, they are unlikely to determine P-BMAL1-S90 oscillation. Finally, on the basis of the BMAL1 phosphorylation pattern ( Fig. 3a,b) , it would seem that CK2a could have a triggering role in multiple phosphorylation events. Our findings demonstrate that CK2a is a BMAL1 kinase that has an essential role in the mammalian clock by regulating BMAL1 nuclear entry. The single Ser90 phosphorylation site is essential for circadian rhythmicity and its mutation causes a phenotype similar to that caused by depletion of CK2a (compare Fig. 2b,c and 2e,f) . These findings suggest that CK2a has a pivotal role in the mammalian circadian clock, by controlling BMAL1 intracellular distribution. Although it is likely that CK2 influences circadian physiology at multiple levels because it phosphorylates a large array of cellular proteins 20 , the remarkable specificity observed here on BMAL1-Ser90 provides a lead to further investigations. Finally, as BMAL1 is SUMOylated and acetylated 4, 7 , the regulatory pathway presented here may participate in the interplay between phosphorylation and other post-translational modifications. 
